Measurements of bone mineral density. Mineral density in metabolic bone disease.
Bone metabolism and thus bone remodelling and bone mineral content are profoundly influenced by many hormonal and metabolic factors. This review presents the state of the art procedures for bone mineral absorptiometry and examines the interactions of endocrine and metabolic diseases and bone mineral content. Preventive and therapeutic modalities of osteoporosis are discussed in this context.
Fischer
M
M
Department of Nuclear Medicine, Klinikum Kassel, Germany.
Raue
F
F
D015519:Bone Density / Q000187:drug effects / Q000502:physiology; D001851:Bone Diseases, Metabolic / Q000175:diagnosis* / Q000503:physiopathology*; D005938:Glucocorticoids / Q000009:adverse effects; D012739:Gonadal Steroid Hormones / Q000494:pharmacology / Q000502:physiology; D006728:Hormones / Q000502:physiology*; D019382:Human Growth Hormone / Q000502:physiology; D006801:Humans; D010281:Parathyroid Hormone / Q000502:physiology; D013002:Somatomedins / Q000502:physiology; D013963:Thyroid Hormones / Q000502:physiology; D014807:Vitamin D / Q000502:physiology
D005938:Glucocorticoids; D012739:Gonadal Steroid Hormones; D006728:Hormones; D010281:Parathyroid Hormone; D013002:Somatomedins; D013963:Thyroid Hormones; D019382:Human Growth Hormone; D014807:Vitamin D